Short Term Outcome & Surgical Risk of Patients Undergoing Mitral Valve Repair vs Replacement in Severe Ischemic Mitral Regurgitation
DOI:
https://doi.org/10.63682/jns.v14i32S.8694Keywords:
Ischemic mitral regurgitation, mitral repair, mitral valve replacement, coronary artery bypass grafting (CABG), ejection fraction, morbidity, mortalityAbstract
Background: Although severe ischemic mitral regurgitation, commonly occurring after myocardial infarction and associated with high mortality, often necessitates surgical intervention, the short-term outcome and surgical risk of patients undergoing mitral valve repair versus replacement remain uncertain, warranting comparison during concomitant coronary artery bypass grafting to assess their impact on morbidity, neurological recovery, and survival.
This study aimed to compare early surgical outcomes of mitral valve repair versus replacement with concomitant coronary artery bypass grafting (CABG) and analyze the impact on morbidity, neurological recovery and short-term survival.
Subjects and methods: In the period between March 2023 and June 2024, 100 patients (77% males, 23% females) were conducted in this study. 37 males (74%) and 13 females (26%) in group A compared to 40 males (80%) and 10 (20%) females in group B. Mean age was 59.74 ± 11.04 in group A, while that in group B was 56.88 ± 9.84 years old. The patients included in this research were CABG patients having severe ischemic mitral regurgitation & underwent surgery for MV (repair or replacement) at Kasr Al-Ainy Hospital and other affiliated hospitals. Clinical and imaging data were prospectively evaluated. Patients were divided into 2 groups depending on the procedure, group A (the repair group) & group B (the replacement group).
Result: Postoperative residual MR occurred in 21% of patients, more frequently in group A (repair, 34%) than in group B (replacement, 8%) (P=0.001), making repair a predictor of postoperative MR. Patients with residual MR had more preoperative MV morphology abnormalities (P=0.015). Multivariable analysis confirmed preoperative MV abnormalities and repair technique as independent predictors (P=0.015, P=0.001). Intraoperative TEE showed more significant MR in group A (P=0.027). Subvalvular apparatus preservation had no statistical significance (P=1). Postoperative MR did not significantly affect EF, renal, or neurological outcomes (GCS: 13.68 ± 2.09 vs. 13.50 ± 2.64; P>0.05). Mitral valve replacement was linked to higher rates of postoperative AF (P=0.001) and increased in-hospital mortality (P=0.046).
Conclusion: Mitral valve replacement is a suitable option for patients with chronic ischemic mitral regurgitation and impaired left ventricular function (over mitral valve repair). It provides better results in terms of freedom from reoperation with comparable valve-related complication rates. Although postoperative residual MR was not associated with significant morbidity and postoperative complications, significant impairment in mid-term survival could not be confirmed by the data
Downloads
Metrics
References
Virk, S. A., Tian, D. H., Sriravindrarajah, A., Dunn, D., Wolfenden, H. D., Suri, R. M., Munkholm-Larsen, S., & Cao, C. (2017). Mitral valve surgery and coronary artery bypass grafting for moderate-to-severe ischemic mitral regurgitation: Meta-analysis of clinical and echocardiographic outcomes. The Journal of Thoracic and Cardiovascular Surgery, 154(1), 127–136.
Perrault LP, Moskowitz AJ, Kron IL, et al. Optimal surgical management of severe ischemic mitral regurgitation: to repair or to replace? J Thorac Cardiovasc Surg 2012;143:1396-1403
Acker, M. A., Parides, M. K., Perrault, L. P., Moskowitz, A. J., Gelijns, A. C., Voisine, P., Smith, P. K., Hung, J. W., Blackstone, E. H., Puskas, J. D., Argenziano, M., Gammie, J. S., Mack, M., Ascheim, D. D., Bagiella, E., Moquete, E. G., Ferguson, T. B., Horvath, K. A., Geller, N. L., … Kron, I. L. (2014). Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. New England Journal of Medicine, 370(1), 23–32.
Lee, M.-L., Chen, T.-H., Huang, H.-D., & Hou, S.-M. (2018). Mitral valve repair versus replacement in patients with ischemic mitral regurgitation. Journal of Thoracic Disease, 10(5), 2820–2828.
Nishimura RA, Otto CM, Bonow RO, et al: 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129:e521–e643, 2014.
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. v, Mack, M., McLeod, C., O’Gara, P. T., Rigolin, V. H., Sundt, T. M., Thompson, A., & Toly, C.. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021; 143(5), e72–e227.
Lam BK, Gillinov AM, Blackstone EH, Rajeswaran J, Yuh B, Bhudia SK, McCarthy PM, Cosgrove DM. Importance of moderate ischemic mitral regurgitation. The Annals of thoracic surgery. 2005 Feb 1;79(2):462-70.
Maltais S, Schaff HV, Daly RC, Suri RM, Dearani JA, Sundt III TM, Enriquez-Sarano M, Topilsky Y, Park SJ. Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: factors that influence survival. The Journal of thoracic and cardiovascular surgery. 2011 Nov 1;142(5):995-1001.
Lorusso R, Gelsomino S, Vizzardi E, et al: Mitral valve repair or replacement for ischemic mitral regurgitation? The Italian Study on the Treatment of Ischemic Mitral Regurgitation (ISTIMIR). J Thorac Cardiovasc Surg 145:128–139, discussion 137–138, 2013.
Tolis Jr G and Sundt 3rd TM. ; Surgical strategies for management of mitral regurgitation: recent evidence from randomized controlled trials. Curr Atheroscler Rep. 2015;17(12):67.
Chan V, Levac-Martinho O, Sohmer B, Elmistekawy E, Ruel M, Mesana TG. When should the mitral valve be repaired or replaced in patients with ischemic mitral regurgitation?. The Annals of thoracic surgery. 2017 Mar 1;103(3):742-7.
Chan V, Ruel M, Mesana TG. Mitral valve replacement is a viable alternative to mitral valve repair for ischemic mitral regurgitation: a case-matched study. The Annals of thoracic surgery. 2011 Oct 1;92(4):1358-66.
Nantsios A, Ahmadvand A, Burwash IG, Chan V, Guo MH, Mesana T, Messika-Zeitoun D, Ramsay T, Rubens FD. Edge-to-edge with partial band mitral valve repair compared to replacement and undersized restrictive annuloplasty for ischemic mitral regurgitation. JTCVS techniques. 2024 Feb 1;23:26-43.
Bax JJ, Braun J, Somer ST, et al: Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation 110:II103– II108, 2004.
Silberman S, Klutstein MW, Sabag T, et al: Repair of ischemic mitral regurgitation: comparison between flexible and rigid annuloplasty rings. Ann Thorac Surg 87:1721–1726, discussion 1726– 1727, 2009
Qiu, Zhibing, Xin Chen, Ming Xu, Yingshuo Jiang, Liqiong Xiao, LeLe Liu, and Liming Wang. "Is mitral valve repair superior to replacement for chronic ischemic mitral regurgitation with left ventricular dysfunction?." Journal of cardiothoracic surgery 5 (2010): 1-9.
Aklog L, Filsoufi F, Flores KQ, et al: Does coronary artery bypass grafting alone correct moderate ischemic mitral regurgitation? Circulation 104:I68–I75, 2001.
Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, Hung JW, Voisine P, Dagenais F, Gillinov AM, Thourani V. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. New England Journal of Medicine. 2016 Jan 28;374(4):344-53.
McGee EC, Gillinov AM, Blackstone EH, et al: Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 128:916–924, 2004.
Hueb AC, Jatene FB, Moreira LF, et al: Ventricular remodeling and mitral valve modifications in dilated cardiomyopathy: new insights from anatomic study. J Thorac Cardiovasc Surg 124:1216– 1224, 2002.
Bolling SF, Pagani FD, Deeb GM, et al: Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 115:381–386, discussion 387–388, 1998.
Obadia, J. F., el Farra, M., Bastien, O. H., Lièvre, M., Martelloni, Y., & Chassignolle, J. F. (1997). Outcome of atrial fibrillation after mitral valve repair. The Journal of Thoracic and Cardiovascular Surgery, 114(2), 179–185.
Tseluyko, V. J., Zhadan, A. v, & Zedginidze, E. T. (2015). [Atrial fibrillation after mitral valve replacement]. Georgian Medical News, 238, 65–69.
Alizadeh-Ghavidel, A., Mirmesdagh, Y., Sharifi, M., Sadeghpour, A., Nakhaeizadeh, R., & Omrani, G. (2013). The impact of sub-valvular apparatus preservation on prosthetic valve dysfunction during mitral valve replacement. Research in Cardiovascular Medicine, 2(1), 55.
Calafiore AM, Refaie R, Iacò AL, Asif M, Al Shurafa HS, Al-Amri H, Romeo A, Di Mauro M. Chordal cutting in ischemic mitral regurgitation: a propensity-matched study. The Journal of Thoracic and Cardiovascular Surgery. 2014 Jul 1;148(1):41-6.
Guy TS, IV, Moainie SL, Gorman JH, III, et al: Prevention of ischemic mitral regurgitation does not influence the outcome of remodeling after posterolateral myocardial infarction. J Am Coll Cardiol 43:377–383, 2004.
Tolis GA, Jr, Korkolis DP, Kopf GS, et al: Revascularization alone (without mitral valve repair) suffices in patients with advanced ischemic cardiomyopathy and mild-to-moderate mitral regurgitation. Ann Thorac Surg 74:1476–1480, discussion 1480–1481, 2002.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
